Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1995
04/19/1995EP0648270A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
04/19/1995EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof
04/19/1995EP0648218A1 Therapeutic nucleosides
04/19/1995EP0648127A1 Type i and type ii surface antigens associated with staphylococcus epidermidis
04/19/1995EP0648119A1 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST $i(MYCOBACTERIUM TUBERCULOSIS)
04/19/1995EP0517796B1 Oligonucleotide analogs
04/19/1995EP0243446B1 Alpha tocopherol-based vesicles
04/19/1995CN1028230C Process for preparing benzoheterocyclic compounds
04/19/1995CN1028206C Purification of pertussis antigens
04/18/1995US5407961 α-substituted benzenemethanamine derivatives and pharmaceutical use
04/18/1995US5407952 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases
04/18/1995US5407943 Azaspiro quinolone antibacterial agents
04/18/1995US5407941 Platelet activating factor antagonist and antihistamine; useful for treating asthma and allergic disorders
04/18/1995US5407931 Bactericides
04/18/1995US5407929 Triazolylthiomethylthio cephalosporin hydrochhloride, its crystalline hydrate and the production of the same
04/18/1995US5407688 Compositions and methods for treating gastrointestinal disorders
04/18/1995CA1335268C Methods of technetium/rhenium labeling of proteins
04/13/1995WO1995009921A1 Platelet-activating factor acetylhydrolase
04/13/1995WO1995009867A1 Antifungal compositions
04/13/1995WO1995009866A1 Glutathione s-transferase-activated compounds
04/13/1995WO1995009865A1 Glutathione s-transferase-activated compounds
04/13/1995WO1995009857A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity
04/13/1995WO1995009847A1 Pyrimidineamine derivatives and processes for the preparation thereof
04/13/1995WO1995009843A1 Hiv protease inhibitors
04/13/1995WO1995009638A1 Improvements relating to antibacterial compositions
04/13/1995WO1995009626A1 Mycophenolate mofetil high dose oral suspensions
04/13/1995WO1995009601A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
04/13/1995WO1995007934A3 Il8 inhibitors
04/13/1995WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy
04/13/1995WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors
04/13/1995CA2173502A1 Antifungal compositions
04/13/1995CA2173109A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
04/13/1995CA2172124A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity
04/13/1995CA2169084A1 Improvements relating to antibacterial compositions
04/13/1995CA2148931A1 Pyrimidineamine derivatives and processes for the preparation thereof
04/12/1995EP0647644A1 Antibacterial pyrido 1,2,3-d,e 1,3,4 benzoxacin derivatives
04/12/1995EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia
04/12/1995EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof
04/12/1995EP0647266A1 D-enzyme compositions and methods of their use
04/12/1995EP0647230A1 Cephalosporins and 1-carba-1-dethia cephalosporins
04/12/1995EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
04/12/1995EP0568546B1 Bridged cyclic ketal derivatives
04/12/1995EP0561827B1 Tetrapeptides deriving from dalbaheptide antibiotics
04/12/1995CN1101289A Live combination vaccine
04/11/1995US5405939 2',5'-phosphorothioate oligoadenylates and their covalent conjugates with polylysine
04/11/1995US5405938 Sequence-specific binding polymers for duplex nucleic acids
04/11/1995US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone
04/11/1995US5405862 Low free formaldehyde methylolhydantoin compositions
04/11/1995US5405861 Triazole compounds and antifungal compositions thereof
04/11/1995US5405844 Tetracyclic antibiotics and processes for their preparation
04/11/1995CA1335201C S-adenosyl methionine inhibitors
04/06/1995WO1995009175A1 Ring-expanded nucleosides and nucleotides
04/06/1995WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
04/06/1995WO1995009011A1 Methods of stimulating phagocytosis
04/06/1995WO1995008993A1 Oral formulations of an antifungal
04/06/1995WO1995008920A1 Substantive antimicrobial phosphates
04/06/1995CA2172728A1 Vaccine for branhamella catarrhalis
04/06/1995CA2172393A1 Methods of stimulating phagocytosis
04/05/1995EP0646649A1 Method of producing iturin A and antifungal agent for profund mycosis
04/05/1995EP0646598A1 New pseudopeptides with antiviral activity containing valine
04/05/1995EP0646597A1 New pseudopeptides with antiviral activity containing valine
04/05/1995EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis
04/05/1995EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis
04/05/1995EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host
04/05/1995EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
04/05/1995EP0646125A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
04/05/1995EP0646004A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
04/05/1995EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
04/05/1995CN1101044A 2-(3-oxoalk(en)yl)-3-isothiazolones and derivatives as antimicrobial agents
04/05/1995CN1100931A Treatment of viral infections
04/05/1995CN1028106C Therapeutic nucleosides
04/04/1995US5403830 Compositions and methods of treating gastrointestinal disorders
04/04/1995US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label
04/04/1995US5403594 Oral spiramycin formulations and method for preparing same
04/04/1995CA1335103C 5'-indolinyl-5beta-amidomethyloxazolidin-2-ones, 3-(fused-ring substituted) phenyl-5beta- amidomethyloxazolidin-2-ones and 3-(nitrogen substituted) phenyl-5beta-amidomethyloxazolidin-2-ones
04/04/1995CA1335083C Fr901228 substance and preparation thereof
04/04/1995CA1335078C Antiviral method for human immunodeficiency virus with bu-3608
03/1995
03/30/1995WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995WO1995008632A1 Immunoreactive antigens of hepatitis e virus
03/30/1995WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995WO1995008555A1 2',5'-oligoadenylate-2',3'-cyclophosphates
03/30/1995WO1995008552A1 Novel substituted propane-2-ol derivatives
03/30/1995WO1995008541A1 Conformationally locked nucleoside analogues
03/30/1995WO1995008540A1 Bis(amidinobenzimidazolyl)alkanes as antiviral agents
03/30/1995WO1995008344A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
03/30/1995WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995CA2170521A1 Immunoreactive antigens of hepatitis e virus
03/29/1995EP0645141A1 Treating water for dermatoses in domestic animals
03/29/1995EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses
03/29/1995EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/29/1995EP0644931A1 Recombinant herpesvirus of turkeys and uses thereof
03/29/1995EP0644886A1 3-substituted carbacephems
03/29/1995EP0644883A1 Enniatines and enniatine derivates used to control endoparasites
03/29/1995EP0644869A1 Ion pairs of hypericin compounds having antiviral activity